c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf456 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Edoardo Sarti und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Macrophages, Mycobacterium tuberculosis, Tuberculosis, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Background
Mycobacterium tuberculosis (MTB) remains a major cause of global mortality, yet natural immunity prevents disease in more than 90% of exposed individuals. Interferon gamma (IFN-γ) is a critical regulator of innate immunity and enhances macrophage antimicrobial responses.
Methods
Using in vitro systems approaches, we compared the effects of IFN-γ exposure before versus after infection. We manipulated c-Myc in primary macrophages with a tetracycline-inducible lentiviral system. c-Myc expression was also analyzed in tissues from murine tuberculosis models and human granulomas.
Results
Preinfection IFN-γ exposure primed macrophages for enhanced bacterial control, whereas postinfection exposure did not. We identified c-Myc signaling as a central determinant of macrophage antimycobacterial function. Inhibition of c-Myc via Omomyc enhanced bacterial control partly through mTORC1-dependent metabolic reprogramming and nitric oxide production. In vivo analyses, including murine models and human clinical histopathology, revealed strong associations between c-Myc expression, MTB persistence, and active tuberculosis. Conclusion c-Myc mediates immune privilege in MTB infection and represents a promising target for host-directed therapies to enhance macrophage function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
- Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
- Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Department of Biomedicine, University of Basel, Basel, Switzerland.
- Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.
ORCID-Profile: Edoardo Sarti, Cédric Dollé, Rebekka Wolfensberger, Katharina Kusejko, Simon Bredl, Roberto F Speck, Melanie Greter, Lucas Boeck, Elizabeth S Gold, Alan H Diercks, Peter Sander, Gregory S Olson, Johannes Nemeth
Förderung
- NIAID NIH HHS
Zitieren
APA
Sarti, E., Dollé, C., Wolfensberger, R., Kusejko, K., Russenberger, D., Bredl, S., Speck, R. F., Greter, M., Rueschoff, J. H., Boeck, L., Mai, D., Jahn, A. N., Gold, E. S., Liu, D., Diercks, A. H., Sander, P., Olson, G. S., & Nemeth, J. (2025). c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf456
Vancouver
Sarti E, Dollé C, Wolfensberger R, Kusejko K, Russenberger D, Bredl S, et al. c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf456
BibTeX
@article{Sarti2025,
author = {Sarti, Edoardo and Dollé, Cédric and Wolfensberger, Rebekka and Kusejko, Katharina and Russenberger, Doris and Bredl, Simon and Speck, Roberto F and Greter, Melanie and Rueschoff, Jan H and Boeck, Lucas and Mai, Dat and Jahn, Ana N and Gold, Elizabeth S and Liu, Dong and Diercks, Alan H and Sander, Peter and Olson, Gregory S and Nemeth, Johannes},
title = {c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf456}
}
EUVIMED